Shatrughn Bhilare

Shatrughn Bhilare

Auto-generated profile, based on publicly available information

Shatrughn Bhilare

Department of Chemistry, Institute of Chemical Technology, Mumbai, India

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2018 in Organic Letters
Verified
Journal Article
Closed access
SBSiva Sankar Murthy Bandaru
Siva Sankar Murthy Bandaru
SBShatrughn Bhilare
Shatrughn Bhilare
NCNicolas Chrysochos
Nicolas Chrysochos
VGVijay Gayakhe
Vijay Gayakhe
ITIvan Trentin
Ivan Trentin
AKAnant Kapdi
Anant Kapdi

30 December 2020 in Organic Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
HSHarshita Shet
Harshita Shet
UPUdaysinh Parmar
Udaysinh Parmar
SBShatrughn Bhilare
Shatrughn Bhilare
AKAnant Kapdi
Anant Kapdi
Caged phosphines are versatile ligands due to their rigid backbones, exhibiting a range of catalytic activities, as depicted through the given pictorial representation.

29 August 2016 in RSC Advances
Verified
Journal Article
Closed access
PDF file
SBShatrughn Bhilare
Shatrughn Bhilare
VGVijay Gayakhe
Vijay Gayakhe
AAAjaykumar V. Ardhapure
Ajaykumar V. Ardhapure
YSYogesh S. Sanghvi
Yogesh S. Sanghvi
CSCarola Schulzke
Carola Schulzke
AKAnant Kapdi
Anant Kapdi
Two new water-soluble phosphatriazene ligands have been synthesized as versatile ligands for complexation reactions with Pd(OAc)2 and utilized for catalyzing column-free Suzuki–Miyaura cross-coupling of various purine and pyrimidine halonucleosides in water. The water-solubility of the catalytic system simplified the isolation of the cross-coupled products to mere filtration, while the catalytically active solution in the filtrate was recycled eight times. A novel copper-free Sonogashira coupling protocol for the nucleosides has also been established via a one-pot synthesis of FV-100, a nucleoside-based drug in phase 3 clinical trials for herpes zoster or shingles treatment. Application of the Heck reaction was demonstrated by the synthesis of another antiviral drug: BVDU.

8 October 2018 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
SBShatrughn Bhilare
Shatrughn Bhilare
SBSiva Sankar Murthy Bandaru
Siva Sankar Murthy Bandaru
JSJagrut Shah
Jagrut Shah
NCNicolas Chrysochos
Nicolas Chrysochos
CSCarola Schulzke
Carola Schulzke
AKAnant Kapdi
Anant Kapdi

10 June 2019 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
SBSiva Sankar Murthy Bandaru
Siva Sankar Murthy Bandaru
SBShatrughn Bhilare
Shatrughn Bhilare
JCJesvita Cardozo
Jesvita Cardozo
NCNicolas Chrysochos
Nicolas Chrysochos
CSCarola Schulzke
Carola Schulzke
AKAnant Kapdi
Anant Kapdi

3 April 2020 in Molecules
Verified
Journal Article
Open access
PDF file
SBShatrughn Bhilare
Shatrughn Bhilare
HSHarshita Shet
Harshita Shet
YSYogesh S. Sanghvi
Yogesh S. Sanghvi
AKAnant Kapdi
Anant Kapdi
Nucleic acid derivatives are imperative biomolecules and are involved in life governing processes. The chemical modification of nucleic acid is a fascinating area for researchers due to the potential activity exhibited as antiviral and antitumor agents. In addition, these molecules are also of interest toward conducting useful biochemical, pharmaceutical, and mutagenic study. For accessing such synthetically useful structures and features, transition-metal catalyzed processes have been proven over the years to be an excellent tool for carrying out the various transformations with ease and under mild reaction conditions. Amidst various transition-metal catalyzed processes available for nucleoside modification, Pd-catalyzed cross-coupling reactions have proven to be perhaps the most efficient, successful, and broadly applicable reactions in both academia and industry. Pd-catalyzed C–C and C–heteroatom bond forming reactions have been widely used for the modification of the heterocyclic moiety in the nucleosides, although a single catalyst system that could address all the different requirements for nucleoside modifications isvery rare or non-existent. With this in mind, we present herein a review showcasing the recent developments and improvements from our research groups toward the development of Pd-catalyzed strategies including drug synthesis using a single efficient catalyst system for the modification of nucleosides and other heterocycles. The review also highlights the improvement in conditions or the yield of various bio-active nucleosides or commercial drugs possessing the nucleoside structural core. Scale ups wherever performed (up to 100 g) of molecules of commercial importance have also been disclosed.